PaxView® SARS CoV 2 MPCR ULFA Kit | V0531N

PaxView® SARS CoV 2 MPCR ULFA Kit | V0531N | PaxGenBio

COVID-19 (Corona Virus disease 2019) is a respiratory infectious disease caused by a novel coronavirus, SARS-CoV-2, that has not been previously identified in humans. The outbreak began in December 2019. Reported illnesses have ranged from mild respiratory symptoms with fever, cough, and shortness of breath to severe illness and death. Most estimates of the incubation period for SARS-CoV-2 range from 1 to 14 days. The case fatality rate is around 2%. PaxView® SARS-CoV-2 MPCR-ULFA Kit is an in vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2 viral RNA in upper respiratory specimens such as oropharyngeal or nasopharyngeal swabs through MPCR-ULFA. The kit detects SARS-CoV-2 and its variants such as Alpha, Beta, Gamma, Delta, and Omicron.

Target: Orf1ab(RdRp) gene and N gene

Sample type: Upper respiratory specimens such as oropharyngeal or nasopharyngeal swabs

Reaction time: 2.5hr